Document Detail


Mega-trials: is meta-analysis an alternative?
MedLine Citation:
PMID:  8834929     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Large scale placebo-controlled trials with clinical end-points are not possible when other compounds with proven efficacy are already available. Hence, the question arises whether the available experience from placebo-controlled phase III trials can be analysed jointly to assess whether an effect on clinical end-points exists. This question was answered for the new ACE inhibitor ramipril, with which five exercise capacity trials were done in similar patients with heart failure. Meta-analysis showed that ramipril reduced the occurrence of the combined event death or hospitalisation by 32% (P = 0.05), based on the customary 'intention-to-treat' comparison for large scale trials. From this analysis, the lesson has been learnt that a drug development programme must be carefully planned to allow for this type of meta-analysis.
Authors:
J Lubsen
Related Documents :
21181129 - Second-generation antidepressants in social anxiety disorder: meta-analysis of controll...
23849899 - Effects of the resting time associated with the number of trials on the total and indiv...
21186969 - Executive function deficits in children with attention-deficit/hyperactivity disorder a...
9927239 - Shortcomings of the randomized controlled trial: a view from the boondocks.
15702609 - A nonparametric comparison of the effectiveness of treatments: a multivariate toxicity-...
19461029 - Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage.
8067649 - Improving office-based physician's prevention practices for sexually transmitted diseases.
2599789 - A pilot study of a modified balint group using cognitive approaches to physician attitu...
22693789 - Prevalence and management of symptoms during the last month of life.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  49 Suppl 1     ISSN:  0031-6970     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  1996  
Date Detail:
Created Date:  1996-12-05     Completed Date:  1996-12-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  S29-33     Citation Subset:  IM    
Affiliation:
SOCAR Research SA, Givrins, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Heart Failure / drug therapy*
Humans
Meta-Analysis as Topic*
Ramipril / therapeutic use*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 87333-19-5/Ramipril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  ACE inhibitors before or after heart failure?
Next Document:  What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taug...